BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 21.43K shares, a 90.48% decline from fiscal 2012.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 224.99K shares, a 96.38% decline from fiscal 2011.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2011 was 6.22M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | ||||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-06 | 0.00 shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | ||||
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-09 | 0.00 shares 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-10 | ||||
| 2018-12-31 | 0.00 shares 10-K · filed 2019-03-15 | ||||
| 2014-06-30 | 65.00K shares 10-Q · filed 2014-08-07 | ||||
| 2013-12-31 | -153.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | 21.43K shares 10-K · filed 2014-02-12 | |||
| 2013-09-30 | 175.00K shares 10-Q · filed 2013-11-14 | ||||
| 2012-12-31 | -2.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | -1.98M shares derived: sum of 2 quarters · filed 2014-02-12 | 224.99K shares 10-K · filed 2014-02-12 | 3.15M shares 10-K · filed 2013-03-29 | |
| 2012-09-30 | 650.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | 2.85M shares 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | 2.20M shares 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | 6.22M shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |